Active Surveillance with Delayed Intervention for Recurrent Low Risk Bladder Cancer [0.03%]
低危复发膀胱癌的延迟干预主动监测疗法
Michael A Gorin,Mark S Soloway
Michael A Gorin
Introduction: Active surveillance with delayed intervention aims to minimize the discomfort, potential complications and costs associated with immediate treatment of recurrent low grade Ta tumors of the bladder. We review...
Process Improvements Positively Impact the Use of Intravesical Mitomycin C after Transurethral Resection of Nonmuscle Invasive Bladder Cancer in a Large, Urban Urology Practice [0.03%]
流程改进对大城市泌尿科中经尿道膀胱肿瘤电切术后使用灌注丝裂霉素C的积极影响
Joseph Cusano,Peter Haddock,Max Jackson et al.
Joseph Cusano et al.
Introduction: We assessed the rate of intravesical mitomycin C therapy in patients with nonmuscle invasive bladder cancer who underwent transurethral resection of the bladder, as well as the impact of procedural changes g...
Utility of the Oncotype DX® Prostate Cancer Assay in Clinical Practice for Treatment Selection in Men Newly Diagnosed with Prostate Cancer: A Retrospective Chart Review Analysis [0.03%]
OncotypeDX前列腺癌检测在临床实践中的应用价值：治疗选择的回顾性图表分析研究
Marc A Dall&#x;Era,Tara Maddala,Louise Polychronopoulos et al.
Marc A Dall&#x;Era et al.
Introduction: The 17-gene Oncotype DX® prostate cancer assay (Genomic Health Inc., Redwood City, California) is a validated, biopsy based gene expression assay that reports the Genomic Prostate Score. Combined with clini...
Editorial Commentary [0.03%]
述评
Allen F Morey
Allen F Morey
Editorial Commentary [0.03%]
述评
Mack Roach
Mack Roach
Does Squamous Differentiation Portend Worse Outcomes in Urothelial Bladder Cancer? [0.03%]
分化型鳞状细胞预示尿路上皮膀胱癌预后不良吗？
David Y Yang,M Francesca Monn,Hristos Z Kaimakliotis et al.
David Y Yang et al.
Introduction: Interest on the impact of variant histology in bladder cancer prognosis is increasing. Although squamous differentiation is the most well characterized, only recently have less common variants gained increas...
How Will the Transition to ICD-10 Affect Urology Coding? An Analysis of ICD-9 Code Use from a Large Group Practice [0.03%]
从一个大型医疗集团实践分析ICD-9编码使用情况看ICD-10转换对泌尿系统疾病编码的影响是多少？
Jonathan N Rubenstein
Jonathan N Rubenstein
Introduction: On October 1, 2015 the ICD (International Classification of Diseases)-10-CM (10th Revision, Clinical Modification) code set replaced ICD-9 (9th Revision) for coding medical encounters in the United States. T...
Editorial Commentary [0.03%]
述评
Brian R Matlaga
Brian R Matlaga
Editorial Commentary [0.03%]
述评
Maxwell Meng
Maxwell Meng